Bluebird bio Inc (NASDAQ:BLUE)’s traded shares stood at 8.69 million during the last session, with the company’s beta value hitting 0.81. At the close of trading, the stock’s price was $0.96, to imply a decrease of -2.73% or -$0.03 in intraday trading. The BLUE share’s 52-week high remains $5.53, putting it -476.04% down since that peak but still an impressive 8.33% since price per share fell to its 52-week low of $0.88. The company has a valuation of $185.67M, with an average of 8.66 million shares over the past 3 months.

Bluebird bio Inc (NASDAQ:BLUE) trade information

After registering a -2.73% downside in the last session, Bluebird bio Inc (BLUE) has traded red over the past five days. The stock hit a weekly high of 1.2300, dropping -2.73% in its intraday price action. The 5-day price performance for the stock is -19.05%, and -33.10% over 30 days. With these gigs, the year-to-date price performance is -30.20%.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 15.14% for the past 5-year period. While 2024 is set for a 10.88% return in earnings, projections for the next 5 years are at 45.80% annually.

BLUE Dividends

Bluebird bio Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Bluebird bio Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.